RC Repair Versus Subacromial Balloon Spacer in Older Adults

April 1, 2024 updated by: Panam Clinic

Randomized Clinical Trial Comparing Rotator Cuff Repair (RCR) With Subacromial Balloon Spacer (SBS) Implantation

The purpose of this pilot study is to assess the feasibility of a full randomized trial design.

Study Overview

Detailed Description

The feasibility objectives are:

  1. Recruitment

    1. To establish an estimate of the proportion of patients screened who are eligible for inclusion, and of those, the proportion who consent.
    2. To establish an estimate of the proportion of eligible patients with medium/large tears versus massive tears.
  2. Surgery -to confirm agreement among surgeons regarding the protocol's standardized surgical techniques of both groups.

Clinical objectives for observational purposes only are as follows:

  1. Patient reported and clinical outcomes.
  2. Number of "failures" in each group (defined as additional surgery and/or having <12% improvement in SANE score from baseline).

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • 70 years of age or older
  • clinical and radiological diagnosis of a full thickness supraspinatus (or larger) RC tear >2cm or more than 1 full tendon
  • ongoing symptoms after 3 months of physiotherapy
  • a tendon amenable to partial or complete repair (as determined by pre-operative MRI)
  • absence glenohumeral arthritis (Hamada < 3)
  • absence of neoplastic diseases at treated site

Exclusion Criteria:

  • previous surgery or pseudoparalysis on study shoulder
  • complete subscapularis deficiency
  • external rotation lag signs
  • avascular necrosis
  • post-infectious arthritis
  • proximal humerus fracture
  • inflammatory arithritis
  • axillary nerve palsy
  • concomitant tendon transfer
  • neuromuscular disorder
  • unable to speak/read English

Intra-operative Exclusion:

-tendon is NOT amenable to partial or complete repair

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Subacromial spacer implantation
A biodegradable balloon implanted arthroscopically between the acromion and humeral head with tenotomy of long head of biceps.
Active Comparator: Rotator Cuff Repair
Rotator cuff repair with tenotomy of long head of biceps.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study feasibility - randomized
Time Frame: 1 year
Percentage of patients randomized
1 year
Study feasibility - recruitment
Time Frame: 1 year
Number of screened patients and proportion that are deemed eligible that consent
1 year
Study feasibility - surgery
Time Frame: 1 year
Consensus among surgeon co-investigators regarding the standardized peri-operative orders and surgical techniques.
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ASES Score
Time Frame: Baseline, pre-operative
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America.
Baseline, pre-operative
ASES Score
Time Frame: 3 Months, post-operative
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
3 Months, post-operative
ASES Score
Time Frame: 6 Months, post-operative
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
6 Months, post-operative
ASES Score
Time Frame: 12 Months, post-operative
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
12 Months, post-operative
ASES Score
Time Frame: 24 Months, post-operative
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994). It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side). The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
24 Months, post-operative
EQ5D-3L
Time Frame: Baseline, pre-operative
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
Baseline, pre-operative
EQ5D-3L
Time Frame: 3 Months, post-operative
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
3 Months, post-operative
EQ5D-3L
Time Frame: 6 Months, post-operative
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
6 Months, post-operative
EQ5D-3L
Time Frame: 12 Months, post-operative
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
12 Months, post-operative
EQ5D-3L
Time Frame: 24 Months, post-operative
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011). A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population. There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive. The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
24 Months, post-operative
SANE Score
Time Frame: Baseline, pre-operative
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
Baseline, pre-operative
SANE Score
Time Frame: 3 Months, post-operative
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
3 Months, post-operative
SANE Score
Time Frame: 6 Months, post-operative
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
6 Months, post-operative
SANE Score
Time Frame: 12 Months, post-operative
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
12 Months, post-operative
SANE Score
Time Frame: 24 Months, post-operative
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019). Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
24 Months, post-operative
Constant Score
Time Frame: Baseline, pre-operative
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
Baseline, pre-operative
Constant Score
Time Frame: 3 Months, post-operative
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
3 Months, post-operative
Constant Score
Time Frame: 6 Months, post-operative
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
6 Months, post-operative
Constant Score
Time Frame: 12 Months, post-operative
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
12 Months, post-operative
Constant Score
Time Frame: 24 Months, post-operative
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987). This score is widely reported in European-based literature. Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
24 Months, post-operative
Range of Motion
Time Frame: Baseline, pre-operative
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
Baseline, pre-operative
Range of Motion
Time Frame: 3 Months, post-oeprative
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
3 Months, post-oeprative
Range of Motion
Time Frame: 6 Months, post-operative
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
6 Months, post-operative
Range of Motion
Time Frame: 12 Months, post-operative
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
12 Months, post-operative
Range of Motion
Time Frame: 24 Months, post-oeprative
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
24 Months, post-oeprative
Isometric Strength
Time Frame: Baseline, pre-operative
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
Baseline, pre-operative
Isometric Strength
Time Frame: 3 Months, post-operative
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
3 Months, post-operative
Isometric Strength
Time Frame: 6 Months, post-operative
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
6 Months, post-operative
Isometric Strength
Time Frame: 12 Months, post-operative
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
12 Months, post-operative
Isometric Strength
Time Frame: 24 Months, post-operative
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
24 Months, post-operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Jarret Woodmass, MD, Pan Am Clinic

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2024

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2027

Study Registration Dates

First Submitted

February 1, 2023

First Submitted That Met QC Criteria

March 27, 2023

First Posted (Actual)

March 28, 2023

Study Record Updates

Last Update Posted (Actual)

April 2, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RCBAL-01-2023

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe